C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton

Experimental Cell Research

Volumn 313, Issue 18, 2007, Pages 3881-3891

  Martín Encabo, Susana ^a   Santos, Eugenio ^a   Guerrero, Carmen ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Actin cytoskeleton; C3G; ERK; PP2A; Transformation suppression

Indexed keywords

ACTIN; C3G PROTEIN; CYTOCHALASIN D; GENE PRODUCT; KSR 1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OKADAIC ACID; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE PP2A; RAS PROTEIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DEPHOSPHORYLATION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HYPOTHESIS; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INTRACELLULAR SPACE; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 35248837376     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.07.036     Document Type: Article

References (47)

1. Gotoh T., Hattori S., Nakamura S., Kitayama H., Noda M., Takai Y., Kaibuchi K., Matsui H., Hatase O., Takahashi H., Kurata T., and Matsuda M. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 15 (1995) 6746-6753
2. Gotoh T., Niino Y., Tokuda M., Hatase O., Nakamura S., Matsuda M., and Hattori S. Activation of R-Ras by Ras-guanine nucleotide-releasing factor. J. Biol. Chem. 272 (1997) 18602-18607
3. de Jong R., van Wijk A., Heisterkamp N., and Groffen J. C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells. Oncogene 17 (1998) 2805-2810
4. Arai A., Nosaka Y., Kohsaka H., Miyasaka N., and Miura O. CrkL activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G. Blood 93 (1999) 3713-3722
5. Arai A., Nosaka Y., Kanda E., Yamamoto K., Miyasaka N., and Miura O. Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta1 integrin-mediated hematopoietic cell adhesion. J. Biol. Chem. 276 (2001) 10453-10462
6. Uemura N., and Griffin J.D. The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration. J. Biol. Chem. 274 (1999) 37525-37532
7. Ohba Y., Ikuta K., Ogura A., Matsuda J., Mochizuki N., Nagashima K., Kurokawa K., Mayer B.J., Maki K., Miyazaki J., and Matsuda M. Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis. EMBO J. 20 (2001) 3333-3341
8. Nosaka Y., Arai A., Miyasaka N., and Miura O. CrkL mediates Ras-dependent activation of the Raf/ERK pathway through the guanine nucleotide exchange factor C3G in hematopoietic cells stimulated with erythropoietin or interleukin-3. J. Biol. Chem. 274 (1999) 30154-30162
9. Ishimaru S., Williams R., Clark E., Hanafusa H., and Gaul U. Activation of the Drosophila C3G leads to cell fate changes and overproliferation during development, mediated by the RAS-MAPK pathway and RAP1. EMBO J. 18 (1999) 145-155
10. Kao S., Jaiswal R.K., Kolch W., and Landreth G.E. Identification of the mechanisms regulating the differential activation of the MAPK cascade by epidermal growth factor and nerve growth factor in PC12 cells. J. Biol. Chem. 276 (2001) 18169-18177
11. Arai A., Kanda E., and Miura O. Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway. Oncogene 21 (2002) 2641-2651
12. Buensuceso C.S., and O'Toole T.E. The association of CRKII with C3G can be regulated by integrins and defines a novel means to regulate the mitogen-activated protein kinases. J. Biol. Chem. 275 (2000) 13118-13125
13. Guerrero C., Fernandez-Medarde A., Rojas J.M., Font de Mora J., Esteban L.M., and Santos E. Transformation suppressor activity of C3G is independent of its CDC25-homology domain. Oncogene 16 (1998) 613-624
14. Guerrero C., Martin-Encabo S., Fernandez-Medarde A., and Santos E. C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth. Oncogene 23 (2004) 4885-4893
15. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12 (2000) 186-192
16. Zhou B., Wang Z.X., Zhao Y., Brautigan D.L., and Zhang Z.Y. The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases. J. Biol. Chem. 277 (2002) 31818-31825
17. Wera S., and Hemmings B.A. Serine/threonine protein phosphatases. Biochem. J. 311 Pt 1 (1995) 17-29
18. Janssens V., and Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353 (2001) 417-439
19. Janssens V., Goris J., and Van Hoof C. PP2A: the expected tumor suppressor. Curr. Opin. Genet. Dev. 15 (2005) 34-41
20. Liu Q., and Hofmann P.A. Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am. J. Physiol, Heart Circ. Physiol. 286 (2004) H2204-H2212
21. Ory S., Zhou M., Conrads T.P., Veenstra T.D., and Morrison D.K. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr. Biol. 13 (2003) 1356-1364
22. Abraham D., Podar K., Pacher M., Kubicek M., Welzel N., Hemmings B.A., Dilworth S.M., Mischak H., Kolch W., and Baccarini M. Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation. J. Biol. Chem. 275 (2000) 22300-22304
23. Wassarman D.A., Solomon N.M., Chang H.C., Karim F.D., Therrien M., and Rubin G.M. Protein phosphatase 2A positively and negatively regulates Ras1-mediated photoreceptor development in Drosophila. Genes Dev. 10 (1996) 272-278
24. Silverstein A.M., Barrow C.A., Davis A.J., and Mumby M.C. Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4221-4226
25. Strack S. Overexpression of the protein phosphatase 2A regulatory subunit Bgamma promotes neuronal differentiation by activating the MAP kinase (MAPK) cascade. J. Biol. Chem. 277 (2002) 41525-41532
26. Van Kanegan M.J., Adams D.G., Wadzinski B.E., and Strack S. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt. J. Biol. Chem. 280 (2005) 36029-36036
27. Adams D.G., Coffee Jr. R.L., Zhang H., Pelech S., Strack S., and Wadzinski B.E. Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes. J. Biol. Chem. 280 (2005) 42644-42654
28. Radha V., Rajanna A., and Swarup G. Phosphorylated guanine nucleotide exchange factor C3G, induced by pervanadate and Src family kinases localizes to the Golgi and subcortical actin cytoskeleton. BMC Cell Biol. 5 (2004) 31
29. Zwartkruis F.J., and Bos J.L. Ras and Rap1: two highly related small GTPases with distinct function. Exp. Cell Res. 253 (1999) 157-165
30. Shivakrupa R., Radha V., Sudhakar C., and Swarup G. Physical and functional interaction between Hck tyrosine kinase and guanine nucleotide exchange factor C3G results in apoptosis, which is independent of C3G catalytic domain. J. Biol. Chem. 278 (2003) 52188-52194
31. Pinna L.A., and Donella-Deana A. Phosphorylated synthetic peptides as tools for studying protein phosphatases. Biochim. Biophys. Acta 1222 (1994) 415-431
32. Fields S., and Song O. A novel genetic system to detect protein-protein interactions. Nature 340 (1989) 245-246
33. Zheng C.F., and Guan K.L. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases. J. Biol. Chem. 268 (1993) 23933-23939
34. Tanoue T., and Nishida E. Docking interactions in the mitogen-activated protein kinase cascades. Pharmacol. Ther. 93 (2002) 193-202
35. Tanoue T., Yamamoto T., and Nishida E. Modular structure of a docking surface on MAPK phosphatases. J. Biol. Chem. 277 (2002) 22942-22949
36. Millward T.A., Zolnierowicz S., and Hemmings B.A. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24 (1999) 186-191
37. Gehringer M.M. Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response. FEBS Lett. 557 (2004) 1-8
38. Chen J., Martin B.L., and Brautigan D.L. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 257 (1992) 1261-1264
39. Chen J., Parsons S., and Brautigan D.L. Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J. Biol. Chem. 269 (1994) 7957-7962
40. Morrison D.K. KSR: a MAPK scaffold of the Ras pathway?. J. Cell Sci. 114 (2001) 1609-1612
41. Liao Y., Satoh T., Gao X., Jin T.G., Hu C.D., and Kataoka T. RA-GEF-1, a guanine nucleotide exchange factor for Rap1, is activated by translocation induced by association with Rap1*GTP and enhances Rap1-dependent B-Raf activation. J. Biol. Chem. 276 (2001) 28478-28483
42. Wu C., Lai C.F., and Mobley W.C. Nerve growth factor activates persistent Rap1 signaling in endosomes. J. Neurosci. 21 (2001) 5406-5416
43. Bos J.L., de Rooij J., and Reedquist K.A. Rap1 signalling: adhering to new models. Nat. Rev., Mol. Cell Biol. 2 (2001) 369-377
44. Westermarck J., Li S.P., Kallunki T., Han J., and Kahari V.M. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol. Cell. Biol. 21 (2001) 2373-2383
45. Letourneux C., Rocher G., and Porteu F. B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J. 25 (2006) 727-738
46. Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev., Mol. Cell Biol. 6 (2005) 827-837
47. Kortum R.L., and Lewis R.E. The molecular scaffold KSR1 regulates the proliferative and oncogenic potential of cells. Mol. Cell. Biol. 24 (2004) 4407-4416